Brighton Jones LLC’s 10x Genomics TXG Stock Holding History

Brighton Jones LLC’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$857K	Sell	22,353 -196	-0.9%	-$5.14K	0.02%	565
2026 Q1	$479K	Buy	+22,549	New	+$451K	0.01%	716
2025 Q4	–	Sell	-22,349	Closed	-$261K	–	882
2025 Q3	$261K	Sell	22,349 -338	-1%	-$4.41K	0.01%	863
2025 Q2	$263K	Buy	+22,687	New	+$207K	0.01%	778
2024 Q2	–	Sell	-5,395	Closed	-$202K	–	666
2024 Q1	$202K	Buy	+5,395	New	+$237K	0.01%	578
2022 Q1	–	Sell	-1,459	Closed	-$217K	–	551
2021 Q4	$217K	Buy	1,459 +13	+0.9%	+$1.99K	0.01%	474
2021 Q3	$211K	Hold	1,446	–	–	0.01%	445
2021 Q2	$283K	Buy	1,446 +5	+0.3%	+$905	0.01%	361
2021 Q1	$261K	Buy	+1,441	New	+$249K	0.02%	340

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brighton Jones LLC's TXG Position: Q2 2026 in Review

Brighton Jones LLC reduced its 10x Genomics (TXG) stake by 0.87% in Q2 2026, selling an estimated $5.14K and leaving 22,353 shares worth $857K. The position accounts for 0.02% of the portfolio, ranked #565.

Brighton Jones LLC first reported a position in TXG in Q1 2021 and has held it in 9 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Brighton Jones LLC held 22,353 shares of 10x Genomics worth $857K as of Q2 2026.
Brighton Jones LLC sold 196 10x Genomics shares in Q2 2026, an estimated $5.14K.
10x Genomics made up 0.02% of Brighton Jones LLC's portfolio in Q2 2026, its #565 holding.
Brighton Jones LLC first reported a position in 10x Genomics in Q1 2021 and has held it in 9 quarters since.
393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.